1. Sen Chandan K. Human wounds and its burden: an updated compendium of es-timates. Adv Wound Care 2019; 8: 39-48.
2.
Korting HC, Schöllmann C, White RJ. Management of minor acute cutaneous wounds: importance of wound healing in a moist environment. JEADV 2011; 25; 130-137.
3.
Schultz GS. Molecular regulation of wound healing. In: Acute and chronic wounds: nursing management, 2nd Edition, St. Louis 1999, 413-429.
4.
Enoch S, Price P. Cellular, molecular and biochemical differences in the pathophys-iology of healing between acute wounds, chronic wounds and wounds in the aged. World Wide Wounds 2004; 1-17.
5.
Boateng JS, Kerr HM, Howard NES i wsp. Wound healing dressings and drug delivery systems: a review. J Pharm Sci 2008; 97: 2892-2923.
6.
Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol 2007; 25: 9-18.
7.
Guo S, Dipietro LA. Factors affecting wound healing. J Dental Res 2010; 89: 219-229.
8.
Auböck J. Biologie der wundheilung. In: Wild T, Auböck J (ed.). Manual der Wundheilung. Chirurgisch-Dermatologischer Leitfaden der Modernen Wundbehandlung New York, Springer, Vienna 2007, 1-9.
9.
Enoch S, Price P. Cellular, molecular and biochemical differences in the pathophysiology of healing between acute wounds, chronic wounds and wounds in the aged. World Wide Wounds 2004; 13: 1-17.
10.
Falabella, AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity. J Am Acad Dermatol 1998; 39: 737-740.
11.
Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000; 8: 13-25.
12.
Korting HC, Schöllmann C, White RJ. Management of minor acute cutaneous wounds: importance of wound healing in a moist environment. J Eur Acad Dermatol Venereol 2011; 25: 130-137.
13.
Moreo K. Understanding and overcoming the challenges of effective case management for patients with chronic wounds. Case Manag 2005; 16: 62-67.
14.
Olsson M, Järbrink K, Divakar U i wsp. The humanistic and economic burden of chronic wounds: A system-atic review. Wound Repair Regen 2019; 27: 114-125.
15.
Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007; 25: 26-32.
16.
Robson MC. Discussion: dry, moist, and wet skin wound repair. Ann Plast Surg 1995; 34: 499-500.
17.
Atiyeh BS, Ioannovich J, Al-Amm CA i wsp. Management of acute and chronic open wounds: the importance of moist environment in op-timal wound healing. Curr Pharm Biotechnol 2002; 3: 179-195.
18.
Harding KG, Jones V, Price P. Topical treatment: which dressing to choose. Diabet Metab Res Rev 2000; 16: 47-50.
19.
Finnegan S, Percival SL. Clinical and antibiofilm efficacy of antimicrobial hydrogels. Adv Wound Care 2015; 4: 398-406.
20.
Roy DC, Tomblyn S, Burmeister DM i wsp. Ciprofloxacin-loaded keratin hydrogels prevent pseudomonas aeruginosa infection and support healing in a porcine full-thickness excisional wound. Adv Wound Care 2015; 4: 457-468.
21.
Ousey K, Cutting KF, Rogers AA i wsp. The importance of hydration in wound healing: reinvigorating the clinical perspective. J Wound Care 2016; 25: 122-130.
22.
Dissemond J, Augustin M, Eming SA i wsp. Modern wound care - practical aspects of non-interventional topical treatment of patients with chronic wounds. JDDG 2014; 12: 541-554.
23.
Field CK, Kerstein MD. Overview of wound healing in a moist environment. Am J Surg 1994; 167: 2-6.
24.
Zhang L, Yin H, Lei X i wsp. A systematic review and meta-analysis of clinical effectiveness and safety of hydrogel dressings in the management of skin wounds. Front Bioeng Biotechnol 2019; 7: 342.
25.
Hämmerle G, Strohal R. Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings. Int Wound J 2014; 13: 182-188.
26.
Meng H, Chen L, Ye Z i wsp. The effect of a self-assembling peptide nanofiber scaffold (peptide) when used as a wound dressing for the treatment of deep second degree burns in rats. J Biomed Mater Res B: Appl Biomater 2009; 89: 379-391.
27.
Eaglstein WH. Moist wound healing with occlusive dressings: a clinical focus. Dermatol Surg 2001; 27: 175-181.
28.
Madden MR, Nolan E, Finkelstein JL i wsp. Comparison of an occlusive and a semi-occlusive dressing and the effect of the wound exudate upon keratinocyte proliferation. J Trauma 1989; 29: 924-931.
29.
Svensjö T, Pomahac B, Yao F i wsp. Accelerated healing of full-thickness skin wounds in a wet environment. Plast Reconstr Surg 2000; 106: 602-614.
30.
Dyson M, Young SR, Hart J i wsp. Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair. J Invest Dermatol 1992; 99: 729-733.
31.
Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surg 1981; 90: 262-270.
32.
Hämmerle G, Strohal R. Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings. Int Wound J 2014; 13: 182-188.
33.
Matiasek J, Kienzl P, Unger LW i wsp. An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty. Int Wound J 2018; 15: 914-920.
34.
Stoica AE, Chircov C, Grumezescu AM. Hydrogel dressings for the treatment of burn wounds: an up-to-date overview. Materials (Basel) 2020; 13: 1-24.
35.
Zhang L, Yin H, Lei X i wsp. A systematic review and meta-analysis of clinical effectiveness and safety of hydrogel dressings in the management of skin wounds. Front Bioeng Biotechnol 2019; 7: 1-16.
36.
Dumville JC, Soares MO, O’Meara S i wsp. Systematic review and mixed treatment comparison: dressings to heal diabetic foot ulcers. Diabetol 2012; 55: 1902-1910.
37.
Lipp C, Kirker K, Agostinho A i wsp. Testing wound dressings using an in vitro wound model. J Wound Care 2010; 19: 220-226.
38.
Mueller SW, Krebsbach LE. Impact of an antimicrobial-impregnated gauze dressing on surgical site infections including methicillin- resistant Staphylococcus aureus infections. Am J Infect Control 2008; 36: 651-655.
39.
Kramer A, Dissemond J, Kim S i wsp. Consensus on wound antisepsis: update 2018. Skin Pharmacol Physiol 2018; 31: 28-58.
40.
Müller G, Langer J, Siebert J i wsp. Residual antimicrobial effect of chlorhexidine digluconate and octenidine dihydrochloride on reconstructed human epidermis. Skin Pharnacol Physiol 2014; 27: s. 1-8.
41.
Marsch G, Mashaqi B, Burgwitz K i wsp. Prevention of pacemaker infections with perioperative antimicrobial treatment: an in vitro study. Europace 2014; 16: 604-611.
42.
Freise J, Kohaus S, Körber A i wsp. Contact sensitization in patients with chronic wounds: results of a prospective investigation. J Eur Acad Dermatol Venereol 2008; 22: 1203-1207.
43.
Kramer A, Dissemond J, Kim S i wsp. Consensus on wound antisepsis: update 2018. Skin Pharmacol Physiol 2018; 31: 28-58.
44.
Gallenkemper G, Rabe E, Bauer R. Contact sensitization in chronic venous insufficiency: modern wound dressings. Contact Dermatitis 1998; 38: 274-278.
45.
Harrison IP, Spada F. Hydrogels for atopic dermatitis and wound management: a superior drug delivery vehicle. Pharmaceutics 2018; 10: 1-13.
46.
Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961; 50: 874-875.
47.
Hämmerle G, Strohal R. Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings. Int Wound J 2014; 13: 182-188.
48.
Matiasek J, Kienzl P, Unger LW i wsp. An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty. Int Wound J 2018; 15: 914-920.
49.
Stoica AE, Chircov C, Grumezescu AM. Hydrogel dressings for the treatment of burn wounds: an up-to-date overview. Materials (Basel) 2020; 13: 1-24.
50.
Assadian O. Octenidine dihydrochloride: chemical characteristics and antimicrobi-al properties. J Wound Care 2016; 25: 3-6.
51.
Koburger T, Hübner NO, Braun M i wsp. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65: 1712-1719.
52.
Al-Doori Z, Goroncy-Bermes P, Gemmell CG i wsp. Low-level exposure of MRSA to octenidine dihydrochloride does not select for resistance. J Antimicrob Chemother 2007; 59: 1280-1281.
53.
Vanscheidt W, Harding KG, Téot L i wsp. Effectiveness and tissue compatibility of a 12-week treatment of chronic venous leg ulcers with an octenidine based antiseptic--a randomized, double-blind controlled study. Int Wound J 2012; 9: 316-323.
54.
Eisenbeiß W, Siemers F, Amtsberg G i wsp. Prospective, double-blinded, randomised controlled trial assessing the effect of an Octenidine-based hydrogel on bacterial colonisation and epithelialization of skin graft wounds in burn patients. Int J Burns Trauma 2012; 2: 71-79.
55.
Stahl J, Braun M, Siebert J i wsp. The effect of a combination of 0.1% octenidine dihydrochloride and 2% 2-phenoxyethanol (octenisept) on wound healing in pigs in vivo and its in vitro percutaneous permeation through intact and barrier disrupted porcine skin. Int Wound J 2010; 7: 62-69.
56.
Radu CA, Gazyakan E, Germann G i wsp. Optimizing Suprathel ®-therapy by the use of Octenidine-Gel®. Burns 2011; 37: 294-298.
57.
Assadian O, Pilcher M, Antunes JNP i wsp. Facilitating wound bed preparation: properties and clinical efficacy of octenidine and octenidine-based products in modern wound management. J Wound Care 2016; 25: 22-23.
58.
Hämmerle G, Strohal R. Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings. Int Wound J 2014; 13: 182-188.
59.
Mościcka P, Cwajda-Białasik J, Szewczyk MT. Owrzodzenie żylne – problem nie tylko osób starszych. Opis trzech przypadków klinicznych. Pielęg Chir Angiol 2017; 11: 5-12
60.
Mościcka P, Cwajda-Białasik J, Jawień A, Szewczyk MT. Uraz zmiażdżeniowo- oparzeniowy kończyny górnej u młodego człowieka – opis przypadku. Pielęg Chir Angiol 2019; 2: 58-61.
61.
Strohal R, Hämmerle G, Braun M. The antiseptic hydrogel wound gel and the process of wound healing: interim analysis of a prospective case controlled clinical study. Oral presentation. European Wound Management Association Conference, Copenhagen 2013.
62.
Sharpe A, Formiga A, Neves J i wsp. Case studies: octenidine in the management of diabetic foot ulcers. Diabet Foot J 2018; 21: 192-197.
63.
Nikolić N, Kienzl P, Tajpara P i wsp. The antiseptic octenidine inhibits langerhans cell activation and modulates cytokine expression upon superficial wounding with tape stripping. J Immunol Res 2019; 2019: 5143635.
64.
Seiser S, Janker L, Zila N i wsp. Octenidine-based hydrogel shows anti-inflammatory and protease-inhibitory capacities in wounded human skin. Sci Rep 2021; 11: 32.
65.
Matiasek J, Kienzl P, Unger LW i wsp. An intra-individual surgical wound comparison shows that octenidine-based hydrogel wound dressing ameliorates scar appearance following abdominoplasty. Int Wound J 2018; 15: 914-920.
66.
Nikolić N, Kienzl P, Tajpara P i wsp. The antiseptic Octenidine inhibits langerhans cell activation and modulates cytokine expression upon superficial wounding with tape stripping. J Immunol Res 2019; 2019: 5143635.
67.
Krasowski G, Jawień A, Tukiendorf A i wsp. A comparison of an antibacterial sandwich dressing vs. dressing containing silver. Wound Rep Reg 2015; 23: 525-530.
68.
Kramer A, Dissemond J, Willy C i wsp. Wundmanagement Konsensus: Auswahl von Wundantiseptika – Aktualisierung des Expertenkonsensus 2018. mhp Verlag GmbH, Wiesbaden 2019.
69.
Mrozikiewicz-Rakowska B, Jawień A, Sopata M i wsp. The organization of health care of patients with diabetic foot syndrome. Leczenie Ran 2015; 12: 83-112.
70.
Sopata M, Jawień A, Mrozikiewicz-Rakowska B i wsp. Wytyczne postępowania miejscowego w ranach niezakażonych, zagrożonych infekcją oraz zakażonych – przegląd dostępnych substancji przeciwdrobnoustrojowych stosowanych w leczeniu ran. Zalecenia
71.
Polskiego Towarzystwa Leczenia Ran. Leczenie Ran 2020; 17: 15-16.
72.
Karpiński T, Sopata M, Mańkowski B. The antimicrobial effectiveness of antiseptics as a challenge in hard to heal wounds. Leczenie Ran 2020; 17: 88-94.
73.
Radischat N, Augustin M, Herberger K i wsp. Influence of human wound exudate on the bactericidal efficacy of antiseptic agents in quantitative suspension tests on the basis of European Standards (DIN EN 13727). Int Wound J 2020; 17: 781-789.
74.
Szewczyk MT, Mościcka P, Cwajda-Białasik J i wsp. Zalecenia profilaktyki zakażeń miejsca operowanego w okresie pooperacyjnej opieki pielęgniarskiej na oddziałach zabiegowych. Pielęg Chir Angiol 2015; 2: 73-91.
75.
Szewczyk MT, Cwajda-Białasik J, Mościcka P i wsp. Zalecenia profilaktyki zakażeń miejsca operowanego i stosowania antybiotykoterapii w okresie przedoperacyjnej opieki pielęgniarskiej na oddziałach zabiegowych. Pielęg Chir Angiol 2015; 2: 39-55
